Catalyst Wire Dossier Catalyst Wire Dossier

Cibinqo

abrocitinib · Pfizer
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Cibinqo, covering 2022-01-14 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Cibinqo (abrocitinib) — Pfizer Europe MA EEIG

See pricing